H-1B sponsorship profile: Myeloid Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Myeloid Therapeutics, Inc filed 12 Labor Condition Applications covering 12 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (12 certified of 12 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Myeloid Therapeutics, Inc’s H-1B petitions range from $65,000 at the low end to $140,000 at the high end, with a petition-weighted average of $94,167. That range reflects the mix of occupations the company sponsors, led by Senior Research Associate, Molecular Biology (3 petitions at $95,000 avg), followed by Research Associate, Discovery Research and Principal Scientist, Discovery Research. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Myeloid Therapeutics, Inc is headquartered in Cambridge, MA under NAICS code 541714, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Myeloid Therapeutics, Inc ranks. By H-1B petition volume, Myeloid Therapeutics, Inc is #14,627 of 119,880 employers nationally and #625 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.